Bandai Namco announced the game sold around 400,000 worldwide with the announcement of the sequel, Project X Zone 2: Brave New World. According to Bandai Namco, the game sold 10 times better than expected in the West. It debuted very high in both Europe and America. In Japan, it sold 85,539 copies in its first week. In terms of sales, the game did pretty well. Critics criticized the repetitive fights and nonsensical plot. The game received average reviews getting a 71.36% on GameRankings and a 70 on Metacritic. Most of them are bosses from the character's games. These characters are recurring enemies with large amounts of health. These characters are added to the pairs to add an extra attack and make them more powerful. Super Robot Taisen OG Saga: Endless Frontier The following have been confirmed to appear as playable characters. There are also items which restore your health and XP Units have varying movement range and attack range so, determining which unit to attack will be more efficient.
Dealing damage and defeating enemies earns the player EXP which increases your level. Reviving a character can only be done at 100%.
The XP bar can be used to use for a special powerful attack or doing special actions like countering an opponet or reducing damage done.
If the characters are adjacent to another unit, they can have that unit use their support attack to deal more damage and pairing the unit with a solo unit adds a solo attack which also increases damage. Each unit has their own XP bar which grows if you attack in sync with a support or solo. Each move works slightly different so with the best timing, the moves can be even more effective especially if the player gets a critical hit, which increases damage. As you progress through the game, the characters get more moves and different abilities to make even larger combos. Rather, you use a unique combat system similar to a fighting game's of attacking your foes and racking up the most combos. The game is a pretty simple SRPG that doesn't particularly use tactics.
0 kommentar(er)
